Regulation of Pancreatic Secretion

Physiology of the Gastrointestinal Tract

Volumn 2, Issue , 2012, Pages 1425-1460

  Liddle, Rodger A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882489353     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382026-6.00052-X     Document Type: Chapter

References (369)

1. Regan PT, Go VL, DiMagno EP Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man. J Lab Clin Med 1980, 96:743-748.
2. Vazquez-Echarri J, Baumgartner D, Singer MV Dose-response effects of atropine on pancreatic secretory response to intravenous cerulein in dogs. Pancreas 1986, 1:341-346.
3. O'Rourke MF, Reidelberger RD, Solomon TE Effects of atropine on pancreatic response to bethanechol, cholecystokinin, and food intake in rats. Am J Physiol 1991, 261:G735-G741.
4. Singer MV, Solomon TE, Rammert H, Caspary F, Niebel W, Goebell H, et al. Effect of atropine on pancreatic response to HCl and secretin. Am J Physiol 1981, 240:G376-280.
5. Chariot J, Nagain C, Hugonet F, Tsocas A, Roze C Control of interdigestive and intraduodenal meal-stimulated pancreatic secretion in rats. Am J Physiol 1990, 259:G198-G204.
6. de Jong AJ, Singer MV, Jansen JB, Niebel W, Rovati LC, Lamers CB Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog. Gut 1991, 32:215-219.
7. Guan D, Spannagel A, Ohta H, Nakano I, Chey WY, Green GM Role of secretin in basal and fat-stimulated pancreatic secretion in conscious rats. Endocrinology 1991, 128:979-982.
8. Valenzuela JE, Lamers CB, Modlin IM, Walsh JH Cholinergic component in the human pancreatic secretory response to intraintestinal oleate. Gut 1983, 24:807-811.
9. Defilippi C, Solomon TE, Valenzuela JE Pancreatic secretory response to sham feeding in humans. Digestion 1982, 23:217-223.
10. Anagnostides A, Chadwick VS, Selden AC, Maton PN Sham feeding and pancreatic secretion. Evidence for direct vagal stimulation of enzyme output. Gastroenterology 1984, 87:109-114.
11. Brugge WR, Burke CA, Izzo RS, Praissman M Role of cholecystokinin in intestinal phase of human pancreatic secretion. Dig Dis Sci 1987, 32:155-163.
12. Hildebrand P, Beglinger C, Gyr K, Jansen JB, Rovati LC, Zuercher M, et al. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 1990, 85:640-646.
13. Fried M, Erlacher U, Schwizer W, Lochner C, Koerfer J, Beglinger C, et al. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991, 101:503-511.
14. Phillips PA, Yang L, Shulkes A, Vonlaufen A, Poljak A, Bustamante S, et al. Pancreatic stellate cells produce acetylcholine and may play a role in pancreatic exocrine secretion. Proc Natl Acad Sci USA 2010, 107:17397-17402.
15. Greenberg GR, McCloy RF, Baron JH, Bryant MG, Bloom SR Gastric acid regulates the release of plasma secretin in man. Eur J Clin Invest 1982, 12:361-372.
16. Keane FB, DiMagno EP, Dozois RR, Go VL Relationships among canine interdigestive exocrine pancreatic and biliary flow, duodenal motor activity, plasma pancreatic polypeptide, and motilin. Gastroenterology 1980, 78:310-316.
17. Keane FB, Dimagno EP, Malagelada JR Duodenogastric reflux in humans: its relationship to fasting antroduodenal motility and gastric, pancreatic, and biliary secretion. Gastroenterology 1981, 81:726-731.
18. Vantrappen GR, Peeters TL, Janssens J The secretory component of the interdigestive migrating motor complex in man. Scand J Gastroenterol 1979, 14:663-667.
19. Layer P, Chan AT, Go VL, DiMagno EP Human pancreatic secretion during phase II antral motility of the interdigestive cycle. Am J Physiol 1988, 254:G249-G253.
20. Lee KY, Shiratori K, Chen YF, Chang TM, Chey WY A hormonal mechanism for the interdigestive pancreatic secretion in dogs. Am J Physiol 1986, 251:G759-G764.
21. Shiratori K, Lee KY, Chang TM, Jo YH, Coy DH, Chey WY Role of pancreatic polypeptide in the regulation of pancreatic exocrine secretion in dogs. Am J Physiol 1988, 255:G535-G541.
22. Malfertheiner P, Sarr MG, Spencer MP, DiMagno EP Effect of duodenectomy on interdigestive pancreatic secretion, gastrointestinal motility, and hormones in dogs. Am J Physiol 1989, 257:G415-G422.
23. Zimmerman DW, Sarr MG, Smith CD, Nicholson CP, Dalton RR, Barr D, et al. Cyclic interdigestive pancreatic exocrine secretion: is it mediated by neural or hormonal mechanisms?. Gastroenterology 1992, 102:1378-1384.
24. King BF, Love JA, Szurszewski JH Intracellular recordings from pancreatic ganglia of the cat. J Physiol 1989, 419:379-403.
25. Maouyo D, Sarfati P, Guan D, Morisset J, Adelson JW Circadian rhythm of exocrine pancreatic secretion in rats: major and minor cycles. Am J Physiol 1993, 264:G792-G800.
26. Borgstrom B Luminal digestion of fats. The Pancreas: Biology, Pathobiology, and Disease 1993, 475-488. Raven Press, New York. 2nd ed. V.L.W. Go, E.P. DiMagno, J.D. Gardner, E. Lebenthal, H.A. Reber, G.A. Scheele (Eds.).
27. Ainsworth MA, Ladegaard L, Svendsen P, Cantor P, Olsen O, Schaffalitzky de Muckadell OB Pancreatic, hepatic, and duodenal mucosal bicarbonate secretion during infusion of secretin and cholecystokinin. Evidence of the importance of hepatic bicarbonate in the neutralization of acid in the duodenum of anaesthetized pigs. Scand J Gastroenterol 1991, 26:1035-1041.
28. Ekelund K, Johansson C Output of bile and pancreatic enzymes after test meals with different fat content. Influence of body weight on pancreatic enzyme composition. Acta Physiol Scand 1980, 110:161-165.
29. Fried M, Mayer EA, Jansen JB, Lamers CB, Taylor IL, Bloom SR, et al. Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal. Gastroenterology 1988, 95:1344-1350.
30. Beglinger C, Fried M, Whitehouse I, Jansen JB, Lamers CB, Gyr K Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels. J Clin Invest 1985, 75:1471-1476.
31. Gullo L, Priori P, Pezzilli R, Biliotti G, Mattioli G, Barbara L Pancreatic secretory response to ordinary meals: studies with pure pancreatic juice. Gastroenterology 1988, 94:428-433.
32. Konturek SJ, Bielanski W, Solomon TE Effects of an antral mucosectomy, L-364,718 and atropine on cephalic phase of gastric and pancreatic secretion in dogs. Gastroenterology 1990, 98:47-55.
33. Schwartz TW Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983, 85:1411-1425.
34. Singer MV Neurohormonal Control of Pancreatic Enzyme Secretion in Animals. The Pancreas: Biology, Pathobiology, and Disease 1993, 425-448. Raven Press Ltd, New York. 2nd ed. V.L.W. Go, E.P. DiMagno, J.D. Gardner, E. Lebenthal, H.A. Reber, G.A. Scheele (Eds.).
35. Becker S, Niebel W, Singer MV Nervous control of gastric and pancreatic secretory response to 2-deoxy-D-glucose in the dog. Digestion 1988, 39:187-196.
36. Chariot J, Roze C, de la Tour J, Vaille C [Vagal non-cholinergic stimulation of external pancreatic secretion in rats (author's transl)]. Gastroenterol Clin Biol 1982, 6:371-378.
37. Holtmann G, Singer MV, Kriebel R, Stacker KH, Goebell H Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzymes, and gastroduodenal motility. Dig Dis Sci 1989, 34:1701-1707.
38. Furukawa N, Okada H Effects of stimulation of the hypothalamic area on pancreatic exocrine secretion in dogs. Gastroenterology 1989, 97:1534-1543.
39. Roze C, Dubrasquet M, Chariot J, Vaille C Central inhibition of basal pancreatic and gastric secretions by beta-endorphin in rats. Gastroenterology 1980, 79:659-664.
40. Lenz HJ, Messmer B, Zimmerman FG Noradrenergic inhibition of canine gallbladder contraction and murine pancreatic secretion during stress by corticotropin-releasing factor. J Clin Invest 1992, 89:437-443.
41. Messmer B, Zimmerman FG, Lenz HJ Regulation of exocrine pancreatic secretion by cerebral TRH and CGRP: role of VIP, muscarinic, and adrenergic pathways. Am J Physiol 1993, 264:G237-G242.
42. Kohler E, Beglinger C, Eysselein V, Grotzinger U, Gyr K Gastrin is not a physiological regulator of pancreatic exocrine secretion in the dog. Am J Physiol 1987, 252:G40-G44.
43. MacGregor I, Parent J, Meyer JH Gastric emptying of liquid meals and pancreatic and biliary secretion after subtotal gastrectomy or truncal vagotomy and pyloroplasty in man. Gastroenterology 1977, 72:195-205.
44. Mayer EA, Thompson JB, Jehn D, Reedy T, Elashoff J, Meyer JH Gastric emptying and sieving of solid food and pancreatic and biliary secretion after solid meals in patients with truncal vagotomy and antrectomy. Gastroenterology 1982, 83:184-192.
45. Kim MS, Lee KY, Chey WY Plasma secretin concentrations in fasting and postprandial states in dog. Am J Physiol 1979, 236:E539-E544.
46. Moore EW, Verine HJ, Grossman MI Pancreatic bicarbonate response to a meal. Acta Hepatogastroenterol (Stuttg) 1979, 26:30-36.
47. Solomon TE Regulation of pancreatic secretion. Clin Gastroenterol 1984, 13:657-678.
48. Liou AP, Chavez DI, Espero E, Hao S, Wank SA, Raybould HE Protein hydrolysate-induced cholecystokinin secretion from enteroendocrine cells is indirectly mediated by the intestinal oligopeptide transporter pept1. Am J Physiol Gastrointest Liver Physiol 2011.
49. Debas HT, Grossman MI Pure cholecystokinin: pancreatic protein and bicarbonate response. Digestion 1973, 9:469-481.
50. Meyer JH, Kelly GA Canine pancreatic responses to intestinally perfused proteins and protein digests. Am J Physiol 1976, 231:682-691.
51. Wang Y, Chandra R, Samsa LA, Gooch B, Fee BE, Cook JM, et al. Amino acids stimulate cholecystokinin release through the calcium-sensing receptor. Am J Physiol Gastrointest Liver Physiol 2010.
52. Liou AP, Sei Y, Zhao X, Feng J, Lu X, Thomas C, et al. The extracellular calcium sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am J Physiol Gastrointest Liver Physiol 2011.
53. Beglinger C, Grossman MI, Solomon TE Interaction between stimulants of exocrine pancreatic secretion in dogs. Am J Physiol 1984, 246:G173-G179.
54. Sharara AI, Bouras EP, Misukonis MA, Liddle RA Evidence for indirect dietary regulation of cholecystokinin release in rats. Am J Physiol 1993, 265:G107-G112.
55. Singer MV, Solomon TE, Grossman MI Effect of atropine on secretion from intact and transplanted pancreas in dog. Am J Physiol 1980, 238:G18-G22.
56. Fink AS, Miller JC, Jehn DW, Meyer JH Digests of protein augment acid-induced canine pancreatic secretion. Am J Physiol 1982, 242:G634-G641.
57. Green GM, Nasset ES Role of dietary protein in rat pancreatic enzyme secretory response to a meal. J Nutr 1983, 113:2245-2252.
58. Liddle RA, Green GM, Conrad CK, Williams JA Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Am J Physiol 1986, 251:G243-G248.
59. Meyer JH, Jones RS Canine pancreatic responses to intestinally perfused fat and products of fat digestion. Am J Physiol 1974, 226:1178-1187.
60. Malagelada JR, Go VL, DiMagno EP, Summerskill WH Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function. J Clin Invest 1973, 52:2160-2165.
61. Fink AS, Luxenburg M, Meyer JH Regionally perfused fatty acids augment acid-induced canine pancreatic secretion. Am J Physiol 1983, 245:G78-G84.
62. 2+-dependent mechanism in the enteroendocrine cell line STC-1. J Physiol 1998, 513(Pt 1):11-18.
63. McLaughlin J, Grazia Luca M, Jones MN, D'Amato M, Dockray GJ, Thompson DG Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 1999, 116:46-53.
64. McLaughlin J Long-chain fatty acid sensing in the gastrointestinal tract. Biochem Soc Trans 2007, 35:1199-1202.
65. Tanaka T, Katsuma S, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol 2008, 377:523-527.
66. Liou AP, Lu X, Sei Y, Zhao X, Pechhold S, Carrero RJ, et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology 2010.
67. Fink AS, Meyer JH Intraduodenal emulsions of oleic acid augment acid-induced canine pancreatic secretion. Am J Physiol 1983, 245:G85-G91.
68. Riepl RL, Lehnert P, Scharl A, Hempen I, Fiedler F, Teufel J, et al. Effect of intraduodenal bile and Na-taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of secretin, pancreatic polypeptide, and gastrin in man. Scand J Gastroenterol 1990, 25:45-53.
69. Miyasaka K, Green GM Effect of partial exclusion of pancreatic juice on rat basal pancreatic secretion. Gastroenterology 1984, 86:114-119.
70. Su CH, Koller M, Toth L, Dreiling DA Enteropancreatic reflexes. 7: The effect of duodenal distention on pancreatic exocrine secretion. Mt Sinai J Med 1986, 53:332-336.
71. Salinas A, Klein E, Triebling AT, Toth L, Dreiling DA Enteropancreatic reflexes. 3: The effect of ileal distention on pancreatic exocrine secretion. Mt Sinai J Med 1986, 53:315-319.
72. Owyang C Negative feedback control of exocrine pancreatic secretion: role of cholecystokinin and cholinergic pathway. J Nutr 1994, 124:1321S-1326S.
73. Dooley CP, Valenzuela JE Duodenal volume and osmoreceptors in the stimulation of human pancreatic secretion. Gastroenterology 1984, 86:23-27.
74. Malagelada JR, Holtermuller KH, McCall JT, Go VL Pancreatic, gallbladder, and intestinal responses to intraluminal magnesium salts in man. Am J Dig Dis 1978, 23:481-485.
75. Inoue K, Fried GM, Wiener I, Sakamoto T, Lilja P, Greeley GH, et al. Effect of divalent cations on gastrointestinal hormone release and exocrine pancreatic secretion in dogs. Am J Physiol 1985, 248:G28-G34.
76. Niederau C, Sonnenberg A, Erckenbrecht J Effects of intravenous infusion of amino acids, fat, or glucose on unstimulated pancreatic secretion in healthy humans. Dig Dis Sci 1985, 30:445-455.
77. Layer P, Hotz J, Eysselein VE, Jansen JB, Lamers CB, Schmitz-Moormann HP, et al. Effects of acute hypercalcemia on exocrine pancreatic secretion in the cat. Gastroenterology 1985, 88:1168-1174.
78. Niebergall-Roth E, Singer MV Central and peripheral neural control of pancreatic exocrine secretion. J Physiol Pharmacol 2001, 52:523-538.
79. Kirchgessner AL, Liu MT Neurohormonal regulation of the pancreas. Neurogastroenterology. From the Basics to the Clinics 2000, 267-287. Kluwer, Dordrecht. M.V. Singer, H.-J. Krammer (Eds.).
80. Singer MV, Niebergall-Roth E Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin. Cell Biol Int 2009, 33:1-9.
81. Debas HT, Konturek SJ, Grossman MI Effect of extragastric and truncal vagotomy on pancreatic secretion in the dog. Am J Physiol 1975, 228:1172-1177.
82. Holst JJ, Schaffalitzky de Muckadell OB, Fahrenkrug J Nervous control of pancreatic exocrine secretion in pigs. Acta Physiol Scand 1979, 105:33-51.
83. Larose L, Poirier GG, Dumont Y, Fregeau C, Blanchard L, Morisset J Modulation of rat pancreatic amylase secretion and muscarinic receptor populations by chronic bethanechol treatment. Eur J Pharmacol 1983, 95:215-223.
84. Holst JJ Neural regulation of pancreatic exocrine function. The Pancreas: Biology, Pathobiology, and Disease 1993, 381-402. Raven Press, New York. 2nd ed. V.L.W. Go, E.P. DiMagno, J.D. Gardner, E. Lebenthal, H.A. Reber, G.A. Scheele (Eds.).
85. Chen MH, Joffe SN, Magee DF, Murphy RF, Naruse S Cyclic changes of plasma pancreatic polypeptide and pancreatic secretion in fasting dogs. J Physiol 1983, 341:453-461.
86. Magee DF, Naruse S Neural control of periodic secretion of the pancreas and the stomach in fasting dogs. J Physiol 1983, 344:153-160.
87. Singer MV, Niebel W, Uhde KH, Hoffmeister D, Goebell H Dose-response effects of atropine on pancreatic response to secretin before and after truncal vagotomy. Am J Physiol 1985, 248:G532-G538.
88. Solomon TE, Grossman MI Effect of atropine and vagotomy on response of transplanted pancreas. Am J Physiol 1979, 236:E186-E190.
89. Fried GM, Ogden WD, Greeley G, Thompson JC Correlation of release and actions of cholecystokinin in dogs before and after vagotomy. Surgery 1983, 93:786-791.
90. Hopman WP, Jansen JB, Lamers CB Plasma cholecystokinin response to a liquid fat meal in vagotomized patients. Ann Surg 1984, 200:693-697.
91. Niebergall-Roth E, Teyssen S, Wetzel D, Hartel M, Beglinger C, Riepl RL, et al. Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy. Am J Physiol 1997, 272:G1550-G1559.
92. Niebergall-Roth E, Teyssen S, Hartel M, Beglinger C, Riepl RL, Singer MV Pancreatic bicarbonate response to intraduodenal tryptophan in dogs: role of muscarinic M1-receptors and cholecystokinin. Int J Pancreatol 1998, 23:31-39.
93. Kirchgessner AL, Gershon MD Innervation and regulation of the pancreas by neurons in the gut. Z Gastroenterol Verh 1991, 26:230-233.
94. Niebergall-Roth E, Singer MV Control of pancreatic exocrine secretion via muscarinic receptors: which subtype(s) are involved? A review. Pancreatology 2003, 3:284-292.
95. Holst JJ, Fahrenkrug J, Knuhtsen S, Jensen SL, Poulsen SS, Nielsen OV Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion. Regul Pept 1984, 8:245-259.
96. Larsson LI, Fahrenkrug J, Holst JJ, Schaffalitzky de Muckadell OB Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves. Life Sci 1978, 22:773-780.
97. Fahrenkrug J, Schaffalitzky de Muckadell OB, Holst JJ, Jensen SL Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid and HCO3. Am J Physiol 1979, 237:E535-E540.
98. Nelson MT, Debas HT, Mulvihill SJ Vagal stimulation of rat exocrine pancreatic secretion occurs via multiple mediators. Gastroenterology 1993, 105:221-228.
99. Shimosegawa T, Asakura T, Kashimura J, Yoshida K, Meguro T, Koizumi M, et al. Neurons containing gastrin releasing peptide-like immunoreactivity in the human pancreas. Pancreas 1993, 8:403-412.
100. Knuhtsen S, Holst JJ, Jensen SL, Knigge U, Nielsen OV Gastrin-releasing peptide: effect on exocrine secretion and release from isolated perfused porcine pancreas. Am J Physiol 1985, 248:G281-G286.
101. Konturek SJ, Krol R, Tasler J Effect of bombesin and related peptides on the release and action of intestinal hormones on pancreatic secretion. J Physiol 1976, 257:663-672.
102. Flowe KM, Welling TH, Mulholland MW Gastrin-releasing peptide stimulation of amylase release from rat pancreatic lobules involves intrapancreatic neurons. Pancreas 1994, 9:513-517.
103. Upp JR, Poston GJ, MacLellan DG, Townsend CM, Barranco SC, Thompson JC Mechanisms of the trophic actions of bombesin on the pancreas. Pancreas 1988, 3:193-198.
104. Schmidt WE, Choudhury AR, Siegel EG, Loser C, Conlon JM, Folsch UR, et al. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides. Regul Pept 1989, 24:67-79.
105. Park HS, Kwon HY, Lee YL, Chey WY, Park HJ Role of GRPergic neurons in secretin-evoked exocrine secretion in isolated rat pancreas. Am J Physiol Gastrointest Liver Physiol 2000, 278:G557-G562.
106. Holst JJ, Knuhtsen S, Nielsen OV Role of gastrin-releasing peptide in neural control of pancreatic exocrine secretion. Pancreas 1989, 4:581-586.
107. McDonald TJ The gastrin-releasing polypeptide (GRP). Adv Metabol Disorders 1988, 11:199-250.
108. Moghimzadeh E, Ekman R, Hakanson R, Yanaihara N, Sundler F Neuronal gastrin-releasing peptide in the mammalian gut and pancreas. Neuroscience 1983, 10:553-563.
109. Polak JM, Bloom SR Regulatory peptides -the distribution of two newly discovered peptides: PHI and NPY. Peptides 1984, 5(Suppl 1):79-89.
110. Yanaihara N, Yanaihara C, Mochizuki T, Iwahara K, Fujita T, Iwanaga T Immunoreactive GRP. Peptides 1981, 2(Suppl 2):185-191.
111. Feurle GE, Reinecke M Neurotensin interacts with carbachol, secretin, and caerulein in the stimulation of the exocrine pancreas of the rat in vitro. Regul Pept 1983, 7:137-143.
112. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 1983, 304:129-135.
113. Seifert H, Sawchenko P, Chesnut J, Rivier J, Vale W, Pandol SJ Receptor for calcitonin gene-related peptide: binding to exocrine pancreas mediates biological actions. Am J Physiol 1985, 249:G147-G151.
114. Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V, et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982, 116:477-480.
115. Carlei F, Allen JM, Bishop AE, Bloom SR, Polak JM Occurrence, distribution and nature of neuropeptide Y in the rat pancreas. Experientia 1985, 41:1554-1557.
116. Sheikh SP, Holst JJ, Skak-Nielsen T, Knigge U, Warberg J, Theodorsson-Norheim E, et al. Release of NPY in pig pancreas: dual parasympathetic and sympathetic regulation. Am J Physiol 1988, 255:G46-G54.
117. Holst JJ, Orskov C, Knuhtsen S, Sheikh S, Nielsen OV On the regulatory functions of neuropeptide Y (NPY) with respect to vascular resistance and exocrine and endocrine secretion in the pig pancreas. Acta Physiol Scand 1989, 136:519-526.
118. Larsson LI, Rehfeld JF Peptidergic and adrenergic innervation of pancreatic ganglia. Scand J Gastroenterol 1979, 14:433-437.
119. Klein E, Salinas A, Shemesh E, Dreiling DA Effects of autonomic denervation on canine exocrine pancreatic secretion and blood flow. Int J Pancreatol 1988, 3:165-170.
120. Chariot J, Roze C, de la Tour J, Souchard M, Vaille C Modulation of stimulated pancreatic secretion by sympathomimetic amines in the rat. Pharmacology 1983, 26:313-323.
121. Demol P, Sarles H Action of catecholamines on exocrine pancreatic secretion of conscious rats. Arch Int Pharmacodyn Ther 1980, 243:149-163.
122. Chariot J, Appia F, del Tacca M, Tsocas A, Roze C Central and peripheral inhibition of exocrine pancreatic secretion by alpha-2 adrenergic agonists in the rat. Pharmacol Res Commun 1988, 20:707-717.
123. Demol P, Sarles H Inhibition of exocrine pancreatic secretion by alpha-adrenergic blocking agents in conscious rats. Arch Int Pharmacodyn Ther 1980, 243:164-176.
124. Meyer B, Hildebrand P, Meyer M, Stalder GA, Beglinger C Mechanisms of terbutaline-induced inhibition of exocrine pancreatic secretion in humans. Pancreas 1988, 3:399-403.
125. Liddle RA Regulation of pancreatic secretion. Physiology of the Gastrointestinal Tract 2006, Vol 2:1397-1436. Elsevier, Burlington, MA. 4th ed.
126. Iijima F, Iwatsuki K, Chiba S Effects of dopamine on exocrine secretion and cyclic nucleotide concentration in the dog pancreas. Eur J Pharmacol 1983, 92:191-197.
127. Vaysse N, Laval J, Senarens C, Esteve JP, Ribet A Dopamine-stimulated cyclic AMP and binding of [3H] dopamine in acini from dog pancreas. Biochim Biophys Acta 1982, 720:378-383.
128. Delcenserie R, Devaux MA, Sarles H Action of dopamine on the exocrine pancreatic secretion of the intact dog. Br J Pharmacol 1986, 88:189-195.
129. Yi E, Smith TG, Baker RC, Love JA Catecholamines and 5-hydroxytryptamine in tissues of the rabbit exocrine pancreas. Pancreas 2004, 29:218-224.
130. Masuda M, Kanai S, Miyasaka K Inhibitory effect of central dopamine on basal pancreatic secretion in conscious rats. Am J Physiol 1998, 274:G29-G34.
131. Villanueva I, Pinon M, Quevedo-Corona L, Martinez-Olivares R, Racotta R Epinephrine and dopamine colocalization with norepinephrine in various peripheral tissues: guanethidine effects. Life Sci 2003, 73:1645-1653.
132. Stern L, Tenenhouse A, Yu EW Uptake, storage and secretion of 5-hydroxytryptamine and its amino acid precursor by dispersed rat pancreas acinar cells. J Physiol 1983, 340:555-567.
133. Koevary SB, Azmitia EC, McEvoy RC Rat pancreatic serotonergic nerves: morphologic, pharmacologic and physiologic studies. Brain Res 1983, 265:328-332.
134. Koevary SB, McEvoy RC, Azmitia EC Specific uptake of tritiated serotonin in the adult rat pancreas: evidence for the presence of serotonergic fibers. Am J Anat 1980, 159:361-368.
135. Nunez EA, Gershon P, Gershon MD Serotonin and seasonal variation in the pancreatic structure of bats: possible presence of serotonergic axons in the gland. Am J Anat 1980, 159:347-360.
136. Li JP, Chang TM, Chey WY Roles of 5-HT receptors in the release and action of secretin on pancreatic secretion in rats. Am J Physiol Gastrointest Liver Physiol 2001, 280:G595-G602.
137. Chey WY, Chang T Neural hormonal regulation of exocrine pancreatic secretion. Pancreatology 2001, 1:320-335.
138. Yago MD, Manas M, Ember Z, Singh J Nitric oxide and the pancreas: morphological base and role in the control of the exocrine pancreatic secretion. Mol Cell Biochem 2001, 219:107-120.
139. Shimosegawa T, Abe T, Satoh A, Abe R, Kikuchi Y, Koizumi M, et al. NADPH-diaphorase activity in neurons of the mammalian pancreas: coexpression with vasoactive intestinal polypeptide. Gastroenterology 1993, 105:999-1008.
140. Liu HP, Tay SS, Leong SK Nitrergic neurons in the pancreas of newborn guinea pig: their distribution and colocalization with various neuropeptides and dopamine-beta-hydroxylase. J Auton Nerv Syst 1996, 61:248-256.
141. Kirchgessner AL, Liu MT, Gershon MD NADPH diaphorase (nitric oxide synthase)-containing nerves in the enteropancreatic innervation: sources, co-stored neuropeptides, and pancreatic function. J Comp Neurol 1994, 342:115-130.
142. Burrell MA, Montuenga LM, Garcia M, Villaro AC Detection of nitric oxide synthase (NOS) in somatostatin-producing cells of human and murine stomach and pancreas. J Histochem Cytochem 1996, 44:339-346.
143. Vaquero E, Molero X, Puig-Divi V, Malagelada JR Contrasting effects of circulating nitric oxide and nitrergic transmission on exocrine pancreatic secretion in rats. Gut 1998, 43:684-691.
144. Konturek JW, Hengst K, Kulesza E, Gabryelewicz A, Konturek SJ, Domschke W Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion in humans. Gut 1997, 40:86-91.
145. Konturek SJ, Bilski J, Konturek PK, Cieszkowski M, Pawlik W Role of endogenous nitric oxide in the control of canine pancreatic secretion and blood flow. Gastroenterology 1993, 104:896-902.
146. Konturek SJ, Szlachcic A, Dembinski A, Warzecha Z, Jaworek J, Stachura J Nitric oxide in pancreatic secretion and hormone-induced pancreatitis in rats. Int J Pancreatol 1994, 15:19-28.
147. Molero X, Guarner F, Salas A, Mourelle M, Puig V, Malagelada JR Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: effects in acute pancreatitis. Gastroenterology 1995, 108:1855-1862.
148. Jyotheeswaran S, Li P, Chang TM, Chey WY Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats. Pancreas 2000, 20:401-407.
149. Maczka M, Thor P, Bilski J, Konturek SJ Nitric oxide and the interrelation between intestinal motility and pancreatic secretion in fasted and fed dogs. J Physiol Pharmacol 1994, 45:285-298.
150. Chey WY, Chang TM Secretin, 100 years later. J Gastroenterol 2003, 38:1025-1035.
151. Faichney A, Chey WY, Kim YC, Lee KY, Kim MS, Chang TM Effect of sodium oleate on plasma secretin concentration and pancreatic secretion in dog. Gastroenterology 1981, 81:458-462.
152. Chey WY, Lee YH, Hendricks JG, Rhodes RA, Tai HH Plasma secretin concentrations in fasting and postprandial state in man. Am J Dig Dis 1978, 23:981-988.
153. Rominger JM, Chey WY, Chang TM Plasma secretin concentrations and gastric pH in healthy subjects and patients with digestive diseases. Dig Dis Sci 1981, 26:591-597.
154. Schaffalitzky de Muckadell OB, Fahrenkrug J, Watt-Boolsen S, Worning H Pancreatic response and plasma secretin concentration during infusion of low dose secretin in man. Scand J Gastroenterol 1978, 13:305-311.
155. You CH, Rominger JM, Chey WY Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans. Gastroenterology 1983, 85:40-45.
156. Jowell PS, Robuck-Mangum G, Mergener K, Branch MS, Purich ED, Fein SH A double-blind, randomized, dose response study testing the pharmacological efficacy of synthetic porcine secretin. Aliment Pharmacol Ther 2000, 14:1679-1684.
157. Solomon TE, Varga G, Zeng N, Wu SV, Walsh JH, Reeve JR Different actions of secretin and Gly-extended secretin predict secretin receptor subtypes. Am J Physiol Gastrointest Liver Physiol 2001, 280:G88-G94.
158. Chey WY, Konturek SJ Plasma secretion and pancreatic secretion in response to liver extract meal with varied pH and exogenous secretin in the dog. J Physiol 1982, 324:263-272.
159. Schaffalitzky de Muckadell OB, Fahrenkrug J, Nielsen J, Westphall I, Worning H Meal-stimulated secretin release in man: effect of acid and bile. Scand J Gastroenterol 1981, 16:981-988.
160. Chey WY, Kim MS, Lee KY, Chang TM Effect of rabbit antisecretin serum on postprandial pancreatic secretion in dogs. Gastroenterology 1979, 77:1268-1275.
161. Garcia M, Hernandez-Lorenzo P, San Roman JI, Calvo JJ Pancreatic duct secretion: experimental methods, ion transport mechanisms and regulation. J Physiol Biochem 2008, 64:243-257.
162. Singer MV, Niebel W, Elashoff J, Grossman MI Does basal cholinergic activity potentiate exogenous secretin for stimulation of pancreatic bicarbonate output in dogs?. Digestion 1982, 24:209-214.
163. Saito A, Williams JA, Kanno T Potentiation of cholecystokinin-induced exocrine secretion by both exogenous and endogenous insulin in isolated and perfused rat pancreata. J Clin Invest 1980, 65:777-782.
164. Lee KY, Zhou L, Ren XS, Chang TM, Chey WY An important role of endogenous insulin on exocrine pancreatic secretion in rats. Am J Physiol 1990, 258:G268-G274.
165. Liddle RA, Goldfine ID, Williams JA Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 1984, 87:542-549.
166. Hashimura E, Shimizu F, Nishino T, Imagawa K, Tateishi K, Hamaoka T Production of rabbit antibody specific for amino-terminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response. J Immunol Methods 1982, 55:375-387.
167. Himeno S, Tarui S, Kanayama S, Kuroshima T, Shinomura Y, Hayashi C, et al. Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassay. Am J Gastroenterol 1983, 78:703-707.
168. Chang TM, Chey WY Radioimmunoassay of cholecystokinin. Dig Dis Sci 1983, 28:456-468.
169. Jansen JB, Lamers CB Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983, 131:305-316.
170. Becker HD, Werner M, Schafmayer A Release of radioimmunologic cholecystokinin in human subjects. Am J Surg 1984, 147:124-129.
171. Izzo RS, Brugge WR, Praissman M Immunoreactive cholecystokinin in human and rat plasma: correlation of pancreatic secretion in response to CCK. Regul Pept 1984, 9:21-34.
172. Turkelson CM, Dale WE, Reidelberger R, Solomon TE Development of cholecystokinin radioimmunoassay using synthetic CCK-10 as immunogen. Regul Pept 1986, 15:205-217.
173. Rehfeld JF Accurate measurement of cholecystokinin in plasma. Clin Chem 1998, 44:991-1001.
174. Eysselein VE, Eberlein GA, Hesse WH, Singer MV, Goebell H, Reeve JR Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood. J Biol Chem 1987, 262:214-217.
175. Turkelson CM, Solomon TE, Bussjaeger L, Turkelson J, Ronk M, Shively JE, et al. Chemical characterization of rat cholecystokinin-58. Peptides 1988, 9:1255-1260.
176. Eberlein GA, Eysselein VE, Hesse WH, Goebell H, Schaefer M, Reeve JR Detection of cholecystokinin-58 in human blood by inhibition of degradation. Am J Physiol 1987, 253:G477-G482.
177. Reeve JR, Green GM, Chew P, Eysselein VE, Keire DA CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am J Physiol Gastrointest Liver Physiol 2003, 285:G255-G265.
178. Yamamoto M, Reeve JR, Keire DA, Green GM Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8. Am J Physiol Gastrointest Liver Physiol 2005, 288:G866-G879.
179. Glatzle J, Raybould HE, Kueper MA, Reeve JR, Zittel TT Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats. Nutr Neurosci 2008, 11:69-74.
180. Criddle DN, Booth DM, Mukherjee R, McLaughlin E, Green GM, Sutton R, et al. Cholecystokinin-58 and cholecystokinin-8 exhibit similar actions on calcium signaling, zymogen secretion, and cell fate in murine pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 2009, 297:G1085-G1092.
181. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985, 75:1144-1152.
182. Burhol PG, Jenssen TG, Lygren I, Schulz TB, Jorde R, Waldum HL Iodination with Iodo-gen and radioimmunoassay of cholecystokinin (CCK) in acidified plasma, CCK release, and molecular CCK components in man. Digestion 1982, 23:156-168.
183. Byrnes DJ, Henderson L, Borody T, Rehfeld JF Radioimmunoassay of cholecystokinin in human plasma. Clin Chim Acta 1981, 111:81-89.
184. Hopman WP, Jansen JB, Rosenbusch G, Lamers CB Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system. Digestion 1987, 38:197-203.
185. Stubbs RS, Stabile BE Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat. Am J Physiol 1985, 248:G347-G352.
186. Gabryelewicz A, Kulesza E, Konturek SJ Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. Scand J Gastroenterol 1990, 25:731-738.
187. Schmidt WE, Creutzfeldt W, Schleser A, Choudhury AR, Nustede R, Hocker M, et al. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol 1991, 260:G197-G206.
188. Cantor P, Olsen O, Gertz BJ, Gjorup I, Worning H Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329. Scand J Gastroenterol 1991, 26:627-637.
189. Burnham DB, McChesney DJ, Thurston KC, Williams JA Interaction of cholecystokinin and vasoactive intestinal polypeptide on function of mouse pancreatic acini in vitro. J Physiol 1984, 349:475-482.
190. Jo YH, Lee KY, Chang TM, Chey WY Role of cholecystokinin in pancreatic bicarbonate secretion in dogs. Pancreas 1991, 6:197-201.
191. Owyang C Physiological mechanisms of cholecystokinin action on pancreatic secretion. Am J Physiol 1996, 271:G1-G7.
192. Li Y, Owyang C Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest 1993, 92:418-424.
193. Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A, et al. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology 1991, 100:537-543.
194. Soudah HC, Lu Y, Hasler WL, Owyang C Cholecystokinin at physiological levels evokes pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol 1992, 263:G102-G107.
195. Li Y, Owyang C Musings on the wanderer: what's new in our understanding of vago-vagal reflexes? V. Remodeling of vagus and enteric neural circuitry after vagal injury. Am J Physiol Gastrointest Liver Physiol 2003, 285:G461-G469.
196. Owyang C, Logsdon CD New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology 2004, 127:957-969.
197. Zarbin MA, Wamsley JK, Innis RB, Kuhar MJ Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. Life Sci 1981, 29:697-705.
198. Ladenheim EE, Speth RC, Ritter RC Reduction of CCK-8 binding in the nucleus of the solitary tract in unilaterally nodosectomized rats. Brain Res 1988, 474:125-129.
199. Li Y, Zhu J, Owyang C Electrical physiological evidence for highand low-affinity vagal CCK-A receptors. Am J Physiol 1999, 277:G469-G477.
200. Li Y, Hao Y, Owyang C High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am J Physiol 1997, 273:G679-G685.
201. Chandra R, Samsa LA, Vigna SR, Liddle RA Pseudopod-like basal cell processes in intestinal cholecystokinin cells. Cell Tissue Res 2010.
202. Furness JB, Jones C, Nurgali K, Clerc N Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog Neurobiol 2004, 72:143-164.
203. Sankaran H, Goldfine ID, Deveney CW, Wong KY, Williams JA Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J Biol Chem 1980, 255:1849-1853.
204. Jensen RT, Lemp GF, Gardner JD Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A 1980, 77:2079-2083.
205. Klueppelberg UG, Powers SP, Miller LJ The efficiency of covalent labeling of the pancreatic cholecystokinin receptor using a battery of crosslinkable and photolabile probes. Receptor 1990, 1:1-11.
206. Sakamoto C, Goldfine ID, Roach E, Williams JA Localization of saturable CCK binding sites in rat pancreatic islets by light and electron microscope autoradiography. Diabetes 1985, 34:390-394.
207. Wank SA, Pisegna JR, de Weerth A Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human. Ann N Y Acad Sci 1994, 713:49-66.
208. Weinberg DS, Ruggeri B, Barber MT, Biswas S, Miknyocki S, Waldman SA Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest 1997, 100:597-603.
209. Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 2001, 121:1380-1390.
210. Nishimori I, Kamakura M, Fujikawa-Adachi K, Nojima M, Onishi S, Hollingsworth MA, et al. Cholecystokinin A and B receptor mRNA expression in human pancreas. Pancreas 1999, 19:109-113.
211. Saillan-Barreau C, Dufresne M, Clerc P, Sanchez D, Corominola H, Moriscot C, et al. Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes 1999, 48:2015-2021.
212. Morisset J, Laine J, Bourassa J, Lessard M, Rome V, Guilloteau P Presence and localization of CCK receptor subtypes in calf pancreas. Regul Pept 2003, 111:103-109.
213. Morisset J, Wong H, Walsh JH, Laine J, Bourassa J Pancreatic CCK(B) receptors: their potential roles in somatostatin release and delta-cell proliferation. Am J Physiol Gastrointest Liver Physiol 2000, 279:G148-G156.
214. Miyasaka K, Shinozaki H, Jimi A, Funakoshi A Amylase secretion from dispersed human pancreatic acini: neither cholecystokinin a nor cholecystokinin B receptors mediate amylase secretion in vitro. Pancreas 2002, 25:161-165.
215. 2+ signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. Gastroenterology 2008, 135:632-641.
216. Li Y, Hao Y, Zhu J, Owyang C Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology 2000, 118:1197-1207.
217. Andrews PL, Davis CJ, Bingham S, Davidson HI, Hawthorn J, Maskell L The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 1990, 68:325-345.
218. Blackshaw LA, Grundy D Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 1993, 45:41-50.
219. Zhu JX, Zhu XY, Owyang C, Li Y Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol 2001, 530:431-442.
220. Li Y, Wu XY, Zhu JX, Owyang C Intestinal serotonin acts as paracrine substance to mediate pancreatic secretion stimulated by luminal factors. Am J Physiol Gastrointest Liver Physiol 2001, 281:G916-G923.
221. Li Y, Wu XY, Owyang C Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurones. J Physiol 2004, 559:651-662.
222. Mussa BM, Sartor DM, Verberne AJ Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents. Eur J Pharmacol 2008, 601:198-206.
223. Baca I, Feurle GE, Schwab A, Mittmann U, Knauf W, Lehnert T Effect of neurotensin on exocrine pancreatic secretion in dogs. Digestion 1982, 23:174-183.
224. Khalil T, Fujimura M, Greeley GH, Townsend CM, Thompson JC Neurotensin stimulates pancreatic exocrine secretion in rats. Regul Pept 1986, 15:279-284.
225. Gullo L The effect of neurotensin on pure pancreatic secretion in man. Scand J Gastroenterol 1987, 22:343-348.
226. Feurle GE, Hofmann G, Carraway R, Baca I Reproduction of postprandial neurotensin plasma levels by intravenous neurotensin and the effect of neurotensin on exocrine pancreatic secretion in humans. Pancreas 1986, 1:329-334.
227. Fletcher DR, Blackburn AM, Adrian TE, Chadwick VS, Bloom SR Effect of neurotensin on pancreatic function in man. Life Sci 1981, 29:2157-2161.
228. Gullo L, De Giorgio R, Corinaldesi R, Barbara L Neurotensin: a physiological regulator of exocrine pancreatic secretion?. Ital J Gastroenterol 1992, 24:347-351.
229. Demol P, Laugier R, Dagorn JC, Sarles H Inhibition of rat pancreatic secretion by neurotensin: mechanism of action. Arch Int Pharmacodyn Ther 1979, 242:139-148.
230. Feurle GE Xenin-a review. Peptides 1998, 19:609-615.
231. Singh J, Pariente JA, Salido GM The physiological role of histamine in the exocrine pancreas. Inflamm Res 1997, 46:159-165.
232. Gardner JD Regulation of pancreatic exocrine function in vitro: initial steps in the actions of secretagogues. Annu Rev Physiol 1979, 41:55-66.
233. Lajas AI, Pariente JA, Salido GM Histamine and the cAMP pathway in the guinea-pig pancreas. Cell Signal 1995, 7:57-60.
234. Jennings LJ, Salido GM, Pariente JA, Davison JS, Singh J, Sharkey KA Control of exocrine secretion in the guinea-pig pancreas by histamine H3 receptors. Can J Physiol Pharmacol 1996, 74:744-752.
235. Iwatsuki K, Ikeda K, Chiba S Effect of histamine on pancreatic exocrine secretion in the dog. Arch Int Pharmacodyn Ther 1981, 251:166-176.
236. Chremos AN Clinical pharmacology of famotidine: a summary. J Clin Gastroenterol 1987, 9(Suppl 2):7-12.
237. Alcon S, Pozo MJ, Salido GM, Pariente JA Histaminergic modulation of hormonal control in the exocrine guinea-pig pancreas. Inflamm Res 1995, 44:207-211.
238. Kawabata A Gastrointestinal functions of proteinase-activated receptors. Life Sci 2003, 74:247-254.
239. Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS, Bunnett NW Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 1999, 103:261-269.
240. Kim MH, Choi BH, Jung SR, Sernka TJ, Kim S, Kim KT, et al. Protease-activated receptor-2 increases exocytosis via multiple signal transduction pathways in pancreatic duct epithelial cells. J Biol Chem 2008, 283:18711-18720.
241. Laukkarinen JM, Weiss ER, van Acker GJ, Steer ML, Perides G Protease-activated receptor-2 exerts contrasting model-specific effects on acute experimental pancreatitis. J Biol Chem 2008, 283:20703-20712.
242. Singh VP, Bhagat L, Navina S, Sharif R, Dawra RK, Saluja AK Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion. Gut 2007, 56:958-964.
243. Green GM, Lyman RL Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin inhibitor-induced hypersecretion in rats. Proc Soc Exp Biol Med 1972, 140:6-12.
244. Petersen H, Grossman MI Pancreatic exocrine secretion in anesthetized and conscious rats. Am J Physiol 1977, 233:E530-E536.
245. Green GM, Nasset ES Importance of bile in regulation of intraluminal proteolytic enzyme activities in the rat. Gastroenterology 1980, 79:695-702.
246. Green GM, Levan VH Inhibition of rat pancreatic secretion by elastase. IRCS Med. Sci 1985, 13:153-154.
247. Fushiki T, Fukuoka S, Iwai K Stimulatory effect of an endogenous peptide in rat pancreatic juice on pancreatic enzyme secretion in the presence of atropine: evidence for different mode of action of stimulation from exogenous trypsin inhibitors. Biochem Biophys Res Commun 1984, 118:532-537.
248. Solomon TE Regulation of exocrine pancreatic cell proliferation and enzyme synthesis. Physiology of the Gastrointestinal Tract 1981, 873-892. Raven Press, New York. L.R. Johnson (Ed.).
249. Andren-Sandberg A, Ihse I Regulatory effects on the pancreas of intraduodenal pancreatic juice and trypsin in the Syrian golden hamster. Scand J Gastroenterol 1983, 18:697-706.
250. Solomon TE Control of exocrine pancreatic secretion. Physiology of the Gastrointestinal Tract 1994, Raven Press, New York. 3rd ed. L.R. Johnson (Ed.).
251. Adler G, Drewe J, Steinmetz A, Liyanage K, Beglinger C Pancreatic secretory responses to long-term infusions of secretin and cerulein in humans. Pancreas 1990, 5:685-692.
252. Dlugosz J, Folsch UR, Creutzfeldt W Inhibition of intraduodenal trypsin does not stimulate exocrine pancreatic secretion in man. Digestion 1983, 26:197-204.
253. Hotz J, Ho SB, Go VL, DiMagno EP Short-term inhibition of duodenal tryptic activity does not affect human pancreatic, biliary, or gastric function. J Lab Clin Med 1983, 101:488-495.
254. Rinderknecht H, Renner IG, Abramson SB, Carmack C Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 1984, 86:681-692.
255. Thorsen LI, Holm H, Reseland JE, Bjornsen S, Hanssen LE, Brosstad F Characterization of a human trypsin resistant to Kunitz soybean trypsin inhibitor. Studies of duodenal juices after tube instillation of raw soybean extract. Scand J Gastroenterol 1991, 26:589-598.
256. Liener IE, Goodale RL, Deshmukh A, Satterberg TL, Ward G, DiPietro CM, et al. Effect of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas. Gastroenterology 1988, 94:419-427.
257. Levan VH, Liddle RA, Green GM Jejunal bypass stimulation of pancreatic growth and cholecystokinin secretion in rats: importance of luminal nutrients. Gut 1987, 28(Suppl:25-9).
258. Wisner JR, McLaughlin RE, Rich KA, Ozawa S, Renner IG Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Gastroenterology 1988, 94:109-113.
259. Zucker KA, Adrian TE, Bilchik AJ, Modlin IM Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals. Am J Physiol 1989, 257:G511-G516.
260. Green GM, Levan VH, Liddle RA Plasma cholecystokinin and pancreatic growth during adaptation to dietary protein. Am J Physiol 1986, 251:G70-G74.
261. Miyasaka K, Guan DF, Liddle RA, Green GM Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide. Am J Physiol 1989, 257:G175-G181.
262. Louie DS, May D, Miller P, Owyang C Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Am J Physiol 1986, 250:G252-G259.
263. Lu L, Louie D, Owyang C A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion. Am J Physiol 1989, 256:G430-G435.
264. Levan VH, Green GM Effect of atropine on rat pancreatic secretory response to trypsin inhibitors and protein. Am J Physiol 1986, 251:G64-G69.
265. Guan D, Ohta H, Tawil T, Liddle RA, Green GM CCK-releasing activity of rat intestinal secretion: effect of atropine and comparison with monitor peptide. Pancreas 1990, 5:677-684.
266. Cuber JC, Vilas F, Charles N, Bernard C, Chayvialle JA Bombesin and nutrients stimulate release of CCK through distinct pathways in the rat. Am J Physiol 1989, 256:G989-G996.
267. Herzig KH, Louie DS, Owyang C Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide. Am J Physiol 1994, 266:G1156-G1161.
268. Spannagel AW, Green GM, Guan D, Liddle RA, Faull K, Reeve JR Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc Natl Acad Sci USA 1996, 93:4415-4420.
269. Herzig KH, Schon I, Tatemoto K, Ohe Y, Li Y, Folsch UR, et al. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proc Natl Acad Sci USA 1996, 93:7927-7932.
270. Tarasova N, Spannagel AW, Green GM, Gomez G, Reed JT, Thompson JC, et al. Distribution and localization of a novel cholecystokinin-releasing factor in the rat gastrointestinal tract. Endocrinology 1997, 138:5550-5554.
271. Wang Y, Prpic V, Green GM, Reeve JR, Liddle RA Luminal CCK-releasing factor stimulates CCK release from human intestinal endocrine and STC-1 cells. Am J Physiol Gastrointest Liver Physiol 2002, 282:G16-G22.
272. Li Y, Hao Y, Owyang C Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin. J Clin Invest 2000, 105:351-359.
273. Steyaert H, Tonon MC, Tong Y, Smihrouet F, Testart J, Pelletier G, et al. Distribution and characterization of endogenous benzodiazepine receptor ligand (endozepine)-like peptides in the rat gastrointestinal tract. Endocrinology 1991, 129:2101-2109.
274. Yoshida H, Tsunoda Y, Owyang C Diazepam-binding inhibitor33-50 elicits Ca2+ oscillation and CCK secretion in STC-1 cells via L-type Ca2+ channels. Am J Physiol 1999, 276:G694-G702.
275. Iwai K, Fukuoka S, Fushiki T, Kodaira T, Ikei N Elevation of plasma CCK concentration after intestinal administration of a pancreatic enzyme secretion-stimulating peptide purified from rat bile-pancreatic juice: analysis with N-terminal region specific radioimmunoassay. Biochem Biophys Res Commun 1986, 136:701-706.
276. Bouras EP, Misukonis MA, Liddle RA Role of calcium in monitor peptide-stimulated cholecystokinin release from perifused intestinal cells. Am J Physiol 1992, 262:G791-G796.
277. Liddle RA, Misukonis MA, Pacy L, Balber AE Cholecystokinin cells purified by fluorescence-activated cell sorting respond to monitor peptide with an increase in intracellular calcium. Proc Natl Acad Sci U S A 1992, 89:5147-5151.
278. Tsuzuki S, Fushiki T, Kondo A, Murayama H, Sugimoto E Effect of a high-protein diet on the gene expression of a trypsin-sensitive, cholecystokinin-releasing peptide (monitor peptide) in the pancreas. Eur J Biochem 1991, 199:245-252.
279. Tsuzuki S, Kondo A, Fushiki T, Sugimoto E Monitor peptide gene expression is increased by exogenous CCK in the rat pancreas and in a rat pancreatic acinar cell line (AR4-2J). FEBS Lett 1992, 307:386-388.
280. McVey DC, Romac JM, Clay WC, Kost TA, Liddle RA, Vigna SR Monitor peptide binding sites are expressed in the rat liver and small intestine. Peptides 1999, 20:457-464.
281. Yamanishi R, Kotera J, Fushiki T, Soneda T, Saitoh T, Oomori T, et al. A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cells. Biochem J 1993, 291(Pt 1):57-63.
282. Imamura M, Lee KY, Song Y, Moriyasu M, Chang TM, Chey WY Role of secretin in negative feedback regulation of postprandial pancreatic secretion in dogs. Gastroenterology 1993, 105:548-553.
283. Sun G, Lee KY, Chang TM, Chey WY Effect of pancreatic juice diversion on secretin release in rats. Gastroenterology 1989, 96:1173-1179.
284. Li P, Lee KY, Chang TM, Chey WY Mechanism of acid-induced release of secretin in rats. Presence of a secretin-releasing peptide. J Clin Invest 1990, 86:1474-1479.
285. Li P, Song Y, Lee KY, Chang TM, Chey WY A secretin releasing peptide exists in dog pancreatic juice. Life Sci 2000, 66:1307-1316.
286. Chang TM, Lee KY, Chang CH, Li P, Song Y, Roth FL, et al. Purification of two secretin-releasing peptides structurally related to phospholipase A2 from canine pancreatic juice. Pancreas 1999, 19:401-405.
287. Li JP, Chang TM, Wagner D, Chey WY Pancreatic phospholipase A2 from the small intestine is a secretin-releasing factor in rats. Am J Physiol Gastrointest Liver Physiol 2001, 281:G526-G532.
288. Chang TM, Chang CH, Wagner DR, Chey WY Porcine pancreatic phospholipase A2 stimulates secretin release from secretin-producing cells. J Biol Chem 1999, 274:10758-10764.
289. Henriksen FW, Worning H External pancreatic response to food and its relation to the maximal secretory capacity in dogs. Gut 1969, 10:209-214.
290. Itoh Z, Honda R, Hiwatashi K Biphasic secretory response of exocrine pancreas to feeding. Am J Physiol 1980, 238:G332-G337.
291. Katschinski M, Dahmen G, Reinshagen M, Beglinger C, Koop H, Nustede R, et al. Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Gastroenterology 1992, 103:383-391.
292. Layer P [Intestinal regulation of pancreatic enzyme secretion: stimulatory and inhibitory mechanisms]. Z Gastroenterol 1992, 30:495-497.
293. Inoue K, Fried GM, Wiener I, Zhu XG, Greeley GH, Thompson JC Colonic inhibition of cholecystokinin release and pancreatic protein secretion in dogs. Surg Gynecol Obstet 1984, 159:423-428.
294. Owyang C, Green L, Rader D Colonic inhibition of pancreatic and biliary secretion. Gastroenterology 1983, 84:470-475.
295. Layer P, Peschel S, Schlesinger T, Goebell H Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol 1990, 258:G196-G201.
296. Harada H, Kochi F, Hanafusa E, Kobayashi T, Oka H, Kimura I Studies on the effect of glucagon on human pancreatic secretion by analysis of endoscopically obtained pure pancreatic juice. Gastroenterol Jpn 1985, 20:28-36.
297. Horiuchi A, Iwatsuki K, Ren LM, Kuroda T, Chiba S Dual actions of glucagon: direct stimulation and indirect inhibition of dog pancreatic secretion. Eur J Pharmacol 1993, 237:23-30.
298. Singh M Effect of glucagon on digestive enzyme synthesis, transport and secretion in mouse pancreatic acinar cells. J Physiol 1980, 306:307-322.
299. Pandol SJ, Sutliff VE, Jones SW, Charlton CG, O'Donohue TL, Gardner JD, et al. Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues. Am J Physiol 1983, 245:G703-G710.
300. Holst JJ Enteroglucagon. Annu Rev Physiol 1997, 59:257-271.
301. Wettergren A, Wojdemann M, Meisner S, Stadil F, Holst JJ The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation. Gut 1997, 40:597-601.
302. Schjoldager BT, Mortensen PE, Christiansen J, Orskov C, Holst JJ GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans. Dig Dis Sci 1989, 34:703-708.
303. Franke A, Keller J, Holst JJ, Grandt D, Goebell H, Layer P Effects of glucagon-like peptide-1 on human pancreatic enzyme secretion. Digestion 1996, 57:227.
304. Holst JJ, Rasmussen TN, Harling H, Schmidt P Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas. Pancreas 1993, 8:80-87.
305. Wettergren A, Wojdemann M, Holst JJ Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol 1998, 275:G984-G992.
306. Gyr K, Beglinger C, Kohler E, Trautzl U, Keller U, Bloom SR Circulating somatostatin. Physiological regulator of pancreatic function?. J Clin Invest 1987, 79:1595-1600.
307. Konturek SJ, Cieszkowski M, Bilski J, Konturek J, Bielanski W, Schally AV Effects of cyclic hexapeptide analog of somatostatin on pancreatic secretion in dogs. Proc Soc Exp Biol Med 1985, 178:68-72.
308. Hildebrand P, Ensinck JW, Gyr K, Mossi S, Leuppi J, Eggenberger C, et al. Evidence for hormonal inhibition of exocrine pancreatic function by somatostatin 28 in humans. Gastroenterology 1992, 103:240-247.
309. Susini C, Esteve JP, Vaysse N, Pradayrol L, Ribet A Somatostatin 28: effects on exocrine pancreatic secretion in conscious dogs. Gastroenterology 1980, 79:720-724.
310. Vatn MH, Schrumpf E, Hanssen KF, Myren J A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man. J Endocrinol Invest 1980, 3:279-282.
311. Esteve JP, Susini C, Vaysse N, Antoniotti H, Wunsch E, Berthon G, et al. Binding of somatostatin to pancreatic acinar cells. Am J Physiol 1984, 247:G62-G69.
312. Singh M Effect of somatostatin on amylase secretion from in vivo and in vitro rat pancreas. Dig Dis Sci 1986, 31:506-512.
313. Matsushita K, Okabayashi Y, Hasegawa H, Koide M, Kido Y, Okutani T, et al. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats. Gastroenterology 1993, 104:1146-1152.
314. Muller MK, Kessel B, Hutt T, Kath R, Layer P, Goebell H Effects of somatostatin-14 on gastric and pancreatic responses to hormonal and neural stimulation using an isolated perfused rat stomach and pancreas preparation. Pancreas 1988, 3:303-310.
315. Shinozaki H, Funakoshi A, Miyasaka K, Miyazaki K, Kitani K Effect of somatostatin on pancreatic enzyme secretion. Gastroenterol Jpn 1988, 23:673-679.
316. Greenberg GR, McCloy RF, Adrian TE, Chadwick VS, Baron JH, Bloom SR Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet 1978, 2:1280-1282.
317. Chance RE, Cieszkowski M, Jaworek J, Konturek SJ, Swierczek J, Tasler J Effect of pancreatic polypeptide and its C-terminal hexapeptide on meal and secretin induced pancreatic secretion in dogs. J Physiol 1981, 314:1-9.
318. Swierczek JS, Konturek SJ, Tasler J, Jaworek J, Cieszkowski M Pancreatic polypeptide and vagal stimulation of gastric and pancreatic secretion in dogs. Hepatogastroenterology 1981, 28:206-209.
319. Beglinger C, Taylor IL, Grossman MI, Solomon TE Pancreatic polypeptide inhibits exocrine pancreatic responses to six stimulants. Am J Physiol 1984, 246:G286-G291.
320. Lonovics J, Guzman S, Devitt PG, Hejtmancik KE, Suddith RL, Rayford PL, et al. Action of pancreatic polypeptide on exocrine pancreas and on release of cholecystokinin and secretin. Endocrinology 1981, 108:1925-1930.
321. Taylor IL Pancreatic polypeptide family: pancreatic polypeptide, neuropeptide Y, and peptide YY. Handbook of Physiology 1989, Vol 6:475-543. American Physiological Society, Bethesda.
322. Konturek SJ, Meyers CA, Kwiecien N, Obtulowicz W, Tasler J, Oleksy J, et al. Effect of human pancreatic polypeptide and its C-terminal hexapeptide on pancreatic secretion in man and in the dog. Scand J Gastroenterol 1982, 17:395-399.
323. Adrian TE, Greenberg GR, Barnes AJ, Christofides ND, Alberti KG, Bloom SR Effects of pancreatic polypeptide on motilin and circulating metabolites in man. Eur J Clin Invest 1980, 10:235-240.
324. Louie DS, Williams JA, Owyang C Action of pancreatic polypeptide on rat pancreatic secretion: in vivo and in vitro. Am J Physiol 1985, 249:G489-G495.
325. Jung G, Louie DS, Owyang C Pancreatic polypeptide inhibits pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol 1987, 253:G706-G710.
326. Fraser PA, Henderson JR The arrangement of endocrine and exocrine pancreatic microcirculation observed in the living rabbit. Q J Exp Physiol Cogn Med Sci 1980, 65:151-158.
327. Naruse S, Kitagawa M, Ishiguro H, Hayakawa T Feedback regulation of pancreatic secretion by peptide YY. Peptides 2002, 23:359-365.
328. Tatemoto K Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 1982, 79:2514-2518.
329. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985, 89:1070-1077.
330. Taylor IL Distribution and release of peptide YY in dog measured by specific radioimmunoassay. Gastroenterology 1985, 88:731-737.
331. Mannon P, Taylor IL The pancreatic polypeptide family. Gut peptides: Biochemistry and Physiology 1994, 341-370. Raven Press, New York. J.H. Walsh, G.J. Dockray (Eds.).
332. Pappas TN, Debas HT, Goto Y, Taylor IL Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol 1985, 248:G118-G123.
333. Pappas TN, Debas HT, Taylor IL Peptide YY: metabolism and effect on pancreatic secretion in dogs. Gastroenterology 1985, 89:1387-1392.
334. Masuda M, Tomita H, Okubo K, Miyasaka K Vagal efferent nerve-dependent inhibitory action of pancreatic polypeptide and peptide YY in conscious rats: comparison with somatostatin. J Auton Nerv Syst 1994, 50:131-138.
335. Deng X, Guarita DR, Pedroso MR, Kreiss C, Wood PG, Sved AF, et al. PYY inhibits CCK-stimulated pancreatic secretion through the area postrema in unanesthetized rats. Am J Physiol Regul Integr Comp Physiol 2001, 281:R645-R653.
336. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, et al. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 1985, 89:494-499.
337. Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986, 324:476-478.
338. Huttner WB, Benedum UM, Chromogranin A and pancreastatin. Nature 1987, 325:305.
339. Sanchez-Margalet V, Lucas M, Goberna R Pancreastatin: further evidence for its consideration as a regulatory peptide. J Mol Endocrinol 1996, 16:1-8.
340. Bretherton-Watt D, Ghatei MA, Bishop AE, Facer P, Fahey M, Hedges M, et al. Pancreastatin distribution and plasma levels in the pig. Peptides 1988, 9:1005-1014.
341. Jensen TD, Holst JJ, Fahrenkrug J Secretion of pancreastatins from the porcine digestive tract. Scand J Gastroenterol 1994, 29:376-384.
342. Funakoshi A, Tateishi K, Shinozaki H, Miyasaka K, Ito T, Wakasugi H Plasma pancreastatin responses after intrajejunal infusion of liquid meal in patients with chronic pancreatitis. Dig Dis Sci 1990, 35:721-725.
343. Funakoshi A, Tateishi K, Shinozaki H, Matsumoto M, Wakasugi H Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). Regul Pept 1990, 30:159-164.
344. Miyasaka K, Funakoshi A, Yasunami Y, Nakamura R, Kitani K, Tamamura H, et al. Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats. Regul Pept 1990, 28:189-198.
345. Herzig KH, Louie DS, Tatemoto K, Chung OY Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release. Am J Physiol 1992, 262:G113-G117.
346. Matyjek R, Herzig KH, Kato S, Zabielski R Exogenous leptin inhibits the secretion of pancreatic juice via a duodenal CCK1-vagal-dependent mechanism in anaesthetized rats. Regul Pept 2003, 114:15-20.
347. Zhang W, Chen M, Chen X, Segura BJ, Mulholland MW Inhibition of pancreatic protein secretion by ghrelin in the rat. J Physiol 2001, 537:231-236.
348. Lai KC, Cheng CH, Leung PS The ghrelin system in acinar cells: localization, expression, and regulation in the exocrine pancreas. Pancreas 2007, 35:e1-e8.
349. Nawrot-Porabka K, Jaworek J, Leja-Szpak A, Szklarczyk J, Macko M, Kot M, et al. The effect of luminal ghrelin on pancreatic enzyme secretion in the rat. Regul Pept 2007, 143:56-63.
350. Chowdhury RS, Forsmark CE Review article: Pancreatic function testing. Aliment Pharmacol Ther 2003, 17:733-750.
351. Conwell DL, Zuccaro G, Purich E, Fein S, Vanlente F, Vargo J, et al. The effect of moderate sedation on exocrine pancreas function in normal healthy subjects: a prospective, randomized, cross-over trial using the synthetic porcine secretin stimulated Endoscopic Pancreatic Function Test (ePFT). Am J Gastroenterol 2005, 100:1161-1166.
352. Stevens T, Conwell DL, Zuccaro G, Van Lente F, Purich E, Khandwala F, et al. A randomized crossover study of secretin-stimulated endoscopic and dreiling tube pancreatic function test methods in healthy subjects. Am J Gastroenterol 2006, 101:351-355.
353. Domschke S, Heptner G, Kolb S, Sailer D, Schneider MU, Domschke W Decrease in plasma amino acid level after secretin and pancreozymin as an indicator of exocrine pancreatic function. Gastroenterology 1986, 90:1031-1038.
354. Maringhini A, Nelson DK, Jones JD, Dimagno EP Is the plasma amino acid consumption test an accurate test of exocrine pancreatic insufficiency?. Gastroenterology 1994, 106:488-493.
355. Jacobson DG, Curington C, Connery K, Toskes PP Trypsin-like immunoreactivity as a test for pancreatic insufficiency. N Engl J Med 1984, 310:1307-1309.
356. Goldberg DM Proteases in the evaluation of pancreatic function and pancreatic disease. Clin Chim Acta 2000, 291:201-221.
357. Kataoka K, Yamane Y, Kato M, Kashima K Diagnosis of chronic pancreatitis using noninvasive tests of exocrine pancreatic function-comparison to duodenal intubation tests. Pancreas 1997, 15:409-415.
358. Scotta MS, Marzani MD, Maggiore G, De Giacomo C, Melzi D'Eril GV, Moratti R Fecal chymotrypsin: a new diagnostic test for exocrine pancreatic insufficiency in children with cystic fibrosis. Clin Biochem 1985, 18:233-234.
359. de Pedro C, Codoceo R, Vazquez P, Hernanz A Fecal chymotrypsin levels in children with pancreatic insufficiency. Clin Biochem 1986, 19:338-340.
360. Cavallini G, Benini L, Brocco G, Riela A, Bovo P, Pederzoli P, et al. The fecal chymotrypsin photometric assay in the evaluation of exocrine pancreatic capacity. Comparison with other direct and indirect pancreatic function tests. Pancreas 1989, 4:300-304.
361. Ammann RW, Akovbiantz A, Hacki W, Largiader F, Schmid M Diagnostic value of the fecal chymotrypsin test in pancreatic insufficiency, particularly chronic pancreatitis: correlation with the pancreozymin-secretin test, fecal fat excretion and final clinical diagnosis. Digestion 1981, 21:281-289.
362. Stein J, Jung M, Sziegoleit A, Zeuzem S, Caspary WF, Lembcke B Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 1996, 42:222-226.
363. Luth S, Teyssen S, Forssmann K, Kolbel C, Krummenauer F, Singer MV Fecal elastase-1 determination: 'gold standard' of indirect pancreatic function tests?. Scand J Gastroenterol 2001, 36:1092-1099.
364. Amann ST, Bishop M, Curington C, Toskes PP Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis. Pancreas 1996, 13:226-230.
365. Gullo L, Ventrucci M, Tomassetti P, Migliori M, Pezzilli R Fecal elastase 1 determination in chronic pancreatitis. Dig Dis Sci 1999, 44:210-213.
366. Andersen BN, Hagen C, Klein HC, Stadil F, Worning H Correlation between exocrine pancreatic secretion and serum concentration of human pancreatic polypeptide in chronic pancreatitis. Scand J Gastroenterol 1980, 15:699-704.
367. Nealon WH, Beauchamp RD, Townsend CM, Boyd G, Shabot M, Thompson JC Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis. Ann Surg 1986, 204:430-437.
368. Pieramico O, Nelson DK, Glasbrenner B, Malfertheiner P Impaired interdigestive pancreatic polypeptide release. Early hormonal disorder in chronic pancreatitis?. Dig Dis Sci 1994, 39:69-74.
369. Lamers CB, Jansen JB, Hafkenscheid JC, Jongerius CM Evaluation of tests of exocrine and endocrine pancreatic function in older patients with cystic fibrosis. Pancreas 1990, 5:65-69.